151 related articles for article (PubMed ID: 29768709)
21. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
[TBL] [Abstract][Full Text] [Related]
22. Imiquimod-oleic acid prodrug-loaded cream reduced drug crystallinity and induced indistinguishable cytotoxicity and apoptosis in mice melanoma tumour.
Sharma A; Sharma D; Baldi A; Jyoti K; Chandra R; Madan J
J Microencapsul; 2019 Dec; 36(8):759-774. PubMed ID: 31587598
[TBL] [Abstract][Full Text] [Related]
23. MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice.
OuYang Q; Pan Y; Luo H; Xuan C; Liu J; Liu J
Int Immunopharmacol; 2016 Oct; 39():369-376. PubMed ID: 27540765
[TBL] [Abstract][Full Text] [Related]
24. Does imiquimod pretreatment optimize 308-nm excimer laser (UVB) therapy in psoriasis patients?
Tacastacas JD; Oyetakin-White P; Soler DC; Young A; Groft S; Honda K; Cooper KD; McCormick TS
Photodermatol Photoimmunol Photomed; 2017 Jul; 33(4):193-202. PubMed ID: 28168735
[TBL] [Abstract][Full Text] [Related]
25. Ameliorative effects of a fusion protein dual targeting interleukin 17A and tumor necrosis factor α on imiquimod-induced psoriasis in mice.
Liu Z; Liu H; Xu P; Yin Q; Wang Y; Opoku YK; Yang J; Song L; Sun X; Zhang T; Yu D; Wang X; Ren G; Li D
Biomed Pharmacother; 2018 Dec; 108():1425-1434. PubMed ID: 30372845
[TBL] [Abstract][Full Text] [Related]
26. The vitamin D
Hau CS; Shimizu T; Tada Y; Kamata M; Takeoka S; Shibata S; Mitsui A; Asano Y; Sugaya M; Kadono T; Sato S; Watanabe S
J Dermatol Sci; 2018 Nov; 92(2):117-126. PubMed ID: 30166055
[TBL] [Abstract][Full Text] [Related]
27. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of imiquimod skin penetration.
Telò I; Pescina S; Padula C; Santi P; Nicoli S
Int J Pharm; 2016 Sep; 511(1):516-523. PubMed ID: 27452419
[TBL] [Abstract][Full Text] [Related]
29. IMQ-induced skin inflammation in mice is dependent on IL-1R1 and MyD88 signaling but independent of the NLRP3 inflammasome.
Rabeony H; Pohin M; Vasseur P; Petit-Paris I; Jégou JF; Favot L; Frouin E; Boutet MA; Blanchard F; Togbe D; Ryffel B; Bernard FX; Lecron JC; Morel F
Eur J Immunol; 2015 Oct; 45(10):2847-57. PubMed ID: 26147228
[TBL] [Abstract][Full Text] [Related]
30. Effect of Topical Application of Black Seed Oil on Imiquimod-Induced Psoriasis-like Lesions in the Thin Skin of Adult Male Albino Rats.
Okasha EF; Bayomy NA; Abdelaziz EZ
Anat Rec (Hoboken); 2018 Jan; 301(1):166-174. PubMed ID: 28926201
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinase landscape in the imiquimod-induced skin inflammation mouse model.
Noddeland HK; Canbay V; Lind M; Savickas S; Jensen LB; Petersson K; Malmsten M; Koch J; Auf dem Keller U; Heinz A
Biochimie; 2024 Mar; ():. PubMed ID: 38513823
[TBL] [Abstract][Full Text] [Related]
32. CXCL17 Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation by Recruiting Myeloid-Derived Suppressor Cells and Regulatory T Cells.
Oka T; Sugaya M; Takahashi N; Takahashi T; Shibata S; Miyagaki T; Asano Y; Sato S
J Immunol; 2017 May; 198(10):3897-3908. PubMed ID: 28389593
[TBL] [Abstract][Full Text] [Related]
33. Original Research: Different imiquimod creams resulting in differential effects for imiquimod-induced psoriatic mouse models.
Luo DQ; Wu HH; Zhao YK; Liu JH; Wang F
Exp Biol Med (Maywood); 2016 Oct; 241(16):1733-8. PubMed ID: 27190266
[TBL] [Abstract][Full Text] [Related]
34. The oral IRAK4 inhibitors zabedosertib and BAY1830839 suppress local and systemic immune responses in a randomized trial in healthy male volunteers.
Jodl SJ; Ten Voorde W; Klein S; Wagenfeld A; Zollmann FS; Feldmüller M; Klarenbeek NB; de Bruin DT; Jansen MAA; Rissmann R; Rohde B; Moerland M
Clin Transl Sci; 2024 Mar; 17(3):e13771. PubMed ID: 38511583
[TBL] [Abstract][Full Text] [Related]
35. Imiquimod activates p53-dependent apoptosis in a human basal cell carcinoma cell line.
Huang SW; Chang SH; Mu SW; Jiang HY; Wang ST; Kao JK; Huang JL; Wu CY; Chen YJ; Shieh JJ
J Dermatol Sci; 2016 Mar; 81(3):182-91. PubMed ID: 26775629
[TBL] [Abstract][Full Text] [Related]
36. Hesperidin inhibits keratinocyte proliferation and imiquimod-induced psoriasis-like dermatitis via the IRS-1/ERK1/2 pathway.
Li X; Xie X; Zhang L; Meng Y; Li N; Wang M; Zhai C; Liu Z; Di T; Zhang L; Li P
Life Sci; 2019 Feb; 219():311-321. PubMed ID: 30658103
[TBL] [Abstract][Full Text] [Related]
37. Ferulic acid altered IL-17A/IL-17RA interaction and protected against imiquimod-induced psoriasis-like skin injury in mice.
Lo HY; Li CC; Cheng HM; Liu IC; Ho TY; Hsiang CY
Food Chem Toxicol; 2019 Jul; 129():365-375. PubMed ID: 31054998
[TBL] [Abstract][Full Text] [Related]
38. Osteopontin deficiency affects imiquimod-induced psoriasis-like murine skin inflammation and lymphocyte distribution in skin, draining lymph nodes and spleen.
Frenzel DF; Borkner L; Scheurmann J; Singh K; Scharffetter-Kochanek K; Weiss JM
Exp Dermatol; 2015 Apr; 24(4):305-7. PubMed ID: 25655893
[TBL] [Abstract][Full Text] [Related]
39. Mediators of Inflammation in Topical Therapy of Skin Cancers.
Voiculescu VM; Lisievici CV; Lupu M; Vajaitu C; Draghici CC; Popa AV; Solomon I; Sebe TI; Constantin MM; Caruntu C
Mediators Inflamm; 2019; 2019():8369690. PubMed ID: 30766448
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory response of mouse skin exposed to the very potent carcinogen dibenzo[a,l]pyrene: a model for tumor promotion.
Casale GP; Higginbotham S; Johansson SL; Rogan EG; Cavalieri EL
Fundam Appl Toxicol; 1997 Mar; 36(1):71-8. PubMed ID: 9073469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
